<DOC>
	<DOCNO>NCT00510185</DOCNO>
	<brief_summary>A randomize study compare early aggressive initially conservative strategy patient &gt; 74 y.o . non-ST-elevation acute coronary syndrome . This study generate secondary one : `` Causes death elderly patient Non-ST-Elevation Acute Coronary Syndrome ; predictor in-hospital follow-up death ''</brief_summary>
	<brief_title>Early Aggressive Versus Initially Conservative Therapy Elderly Patients With Non-ST-Elevation Acute Coronary Syndrome</brief_title>
	<detailed_description>Patients &gt; 74 y.o . non-ST-elevation acute coronary syndrome randomise early aggressive ( coronary angiography within 72 hour follow , indicate , revascularization ) initially conservative strategy ( medical therapy , coronary angiography refractory ischemia ) . As report Amendment 1 , trial stop May 2010 enrolment 313 patient , minimum sample size calculate order achieve 80 % power detect difference primary-endpoint rate 40 % conservative arm 25 % invasive arm , base upon log-rank test survival curve ( 1-beta 0.80 ; 2-tailed alpha 0.05 )</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Over 74 year age . Have symptom suggestive acute myocardial ischemia rest within 48 hour prior randomization , ischemic ECG change elevate level biochemical marker myocardial damage . Provide write informed consent randomization . Secondary cause acute myocardial ischemia . Ongoing myocardial ischemia despite maximally titrate antiischemic therapy ( invasive strategy recommend ) . Ongoing sign acute heart failure despite treatment ( invasive strategy recommend ) . Percutaneous coronary intervention bypass surgery within 30 day prior randomization . A serum creatinine level great 2.5 mg/dL . Active internal bleeding , history hemorrhagic diathesis recent transfusion red blood cell , whole blood platelet . History cerebrovascular accident within previous month . Known current platelet count &lt; 90,000 cells/mL . Gastrointestinal genitourinary bleed clinical significance within 6 week prior randomization . Concomitant severe obstructive lung disease , malignancy neurologic deficit limit followup adherence study protocol . Participation phase another clinical research study involve evaluation another investigational drug device within 30 day prior randomization . Inability give least verbal informed consent study .</criteria>
	<gender>All</gender>
	<minimum_age>74 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>coronary angioplasty</keyword>
	<keyword>coronary artery bypass surgery</keyword>
	<keyword>elderly</keyword>
</DOC>